Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)

This document (A58340) is a response-to-comments regarding the Implantable Continuous Glucose Monitors LCD L38657 and only records comment/notice periods and the final effective date. The provided excerpt contains no coverage indications, limitations, documentation requirements for claims, or frequency limits; consult the final LCD L38657 for the actionable coverage criteria.

"This document is a response-to-comments for LCD L38657 (Implantable Continuous Glucose Monitors); it records the comment period (05/21/2020–07/06/2020), notice period (09/17/2020–11/01/2020), and f..."

Sign up to see full coverage criteria, indications, and limitations.